HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALEBUND-B

33.900

+1.4404.44%

Volume:488.60K

Turnover:16.29M

Market Cap:11.80B

PE:-11.04

High:34.780

Open:31.140

Low:31.140

Close:32.460

52wk High:46.820

52wk Low:22.720

Shares:348.00M

HK Float Shares:236.00M

Volume Ratio:1.76

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.071

ROE:--

ROA:-33.01%

PB:20.08

PE(LYR):-11.04

PS:330.75

Loading ...

Overview Company News Filings

Alebund Pharmaceuticals Adopts Fully Electronic Dissemination of Corporate Communications

Bulletin Express

Alebund Pharma Doses First Patient in Global Phase 2b Hyperphosphatemia Trial

MT Newswires Live

ALEBUND-B Advances Global Phase IIb Trial for Hyperphosphatemia Treatment with First Patient Dosed

Alebund Pharmaceuticals, R1 Therapeutics Partner on Global Development of AP306 Outside Greater China

Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase Iib Multi-regional Clinical Trial of AP306 for Hyperphosphatemia

THOMSON REUTERS

ALEBUND-B Shares Surge Over 11% in Morning Session Following Major Institutional Buys; AP301 Nears NDA Submission

Movement Alert｜Alebund Pharmaceuticals-B Falls 7.56% in Regular Trading, Post-IPO Volatile Pattern Persists as Stock Retreats Over 40% From High

Movement Alert｜Alebund Pharmaceuticals-B Declines 5.26% in Regular Trading, Post-IPO Volatile Pattern Extends as Short-Term Profit-Taking Continues

Movement Alert｜Alebund Pharmaceuticals-B Falls 5.4% in Regular Trading, Short-Term Profit-Taking After Prior Session Surge

ALEBUND-B Shares Surge Over 10% Intraday Following Significant Stake Increases by GIC and LAV

Movement Alert｜Alebund Pharmaceuticals-B Rises 5.07% in Regular Trading, Post-IPO Recovery Extends on Institutional Backing and NDA Progress

Movement Alert｜Alebund Pharmaceuticals-B Falls 8.32% in Regular Trading, Post-IPO Correction Extends After First-Day Doubling

Alebund Pharmaceuticals Jiangsu (SEHK:9637) Jumps After IPO But Is The Valuation Already Priced In

Simply Wall St.

Major Institutional Investors Increase Holdings in ALEBUND-B, Investing Over HK$58 Million

ALEBUND-B Shares Surge Over 13% in Early Trading as AP301 Nears Commercial Launch Following Recent Sell-Off

Movement Alert｜Alebund Pharmaceuticals-B Rises 7.92% in Regular Trading, Trading at 28.74 HKD

Movement Alert｜Alebund Pharmaceuticals-B Falls 21.6% in Regular Trading, Post-IPO Correction Approaches Offer Price

Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI

Crealights, Baige, Alebund Pharmaceuticals Jump in Hong Kong Debut

ALEBUND-B Makes Hong Kong Stock Exchange Debut: Pioneering a New Growth Model for Biotech in Vertical Chronic Disease Arena

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/09637/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"ALEBUND-B","latestPrice":33.9,"timestamp":1787645293105,"preClose":32.46,"halted":0,"volume":488600,"delay":0,"changeRate":0.04436229205175594,"floatShares":236000000,"shares":348000000,"eps":-3.071284,"marketStatus":"Not Yet Opened","change":1.44,"latestTime":"08-25 16:08:13","open":31.14,"high":34.78,"low":31.14,"amount":16289212,"amplitude":0.112138,"askPrice":34.3,"askSize":5400,"bidPrice":33.9,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-2.384,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":32.46,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":1.7561174786997,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":236000000,"roa":"-33.01%","roe":"--","lyrEps":-3.071284,"volumeRatio":1.7561174786997,"shares":348000000,"dividePrice":0,"high":34.78,"amplitude":0.112138,"preClose":32.46,"low":31.14,"week52Low":22.72,"pbRate":"20.08","psRate":"330.75","week52High":46.82,"institutionHeld":0,"latestPrice":33.9,"committee":-0.928571,"eps":-3.071284,"divideRate":0,"volume":488600,"delay":0,"ttmEps":-2.384,"open":31.14,"prevYearClose":22.6,"prevWeekClose":33.12,"prevMonthClose":27.24,"prevQuarterClose":45.92,"fiveDayClose":33.98,"twentyDayClose":27.86,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"09637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1786550400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-08-24","current":-14.219799,"percent":0.410256,"low":-18.066068,"twenty":-13.058353,"median":-11.768252,"eighty":-10.939493,"high":-8.87585,"avg":-12.206412,"sd":1.7771,"marketCap":11031603418},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-03","current":-11.883178,"twenty":-18.03155,"median":-11.883178,"eighty":-9.78101,"marketCap":10290725554},{"date":"2026-07-10","current":-12.164969,"twenty":-13.966639,"median":-11.847257,"eighty":-11.12129,"marketCap":10521825071},{"date":"2026-07-17","current":-10.947234,"twenty":-12.322489,"median":-11.455859,"eighty":-10.783874,"marketCap":9502268378},{"date":"2026-07-24","current":-11.320561,"twenty":-11.939536,"median":-11.377389,"eighty":-10.939493,"marketCap":9828526520},{"date":"2026-07-31","current":-10.642718,"twenty":-11.840073,"median":-11.194259,"eighty":-10.78337,"marketCap":9257574772},{"date":"2026-08-07","current":-12.743391,"twenty":-12.396338,"median":-11.399787,"eighty":-10.889159,"marketCap":11106370909},{"date":"2026-08-14","current":-13.03884,"twenty":-12.987078,"median":-11.462395,"eighty":-10.903987,"marketCap":11378252693},{"date":"2026-08-21","current":-12.870195,"twenty":-13.077865,"median":-11.725167,"eighty":-10.931752,"marketCap":11255905890},{"date":"2026-08-24","current":-12.618266,"twenty":-13.058353,"median":-11.768252,"eighty":-10.939493,"marketCap":11031603418}],"updateTime":1787692434779},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155137463","title":"Alebund Pharmaceuticals Adopts Fully Electronic Dissemination of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1155137463","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155137463?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:21","pubTimestamp":1784712104,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited (“Alebund”) announced that, in line with Rule 2.07A of the Hong Kong Stock Exchange’s paperless listing regime effective 31 December 2023, the company will...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653378085","title":"Alebund Pharma Doses First Patient in Global Phase 2b Hyperphosphatemia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653378085","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653378085?lang=en_us&edition=fundamental","pubTime":"2026-07-22 10:32","pubTimestamp":1784687579,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (HKG:9637) said that the first participant has been randomized and dosed in a global phase 2b clinical trial evaluating AP306 for hyperphosphatemia in patients receiving mainte","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188002342","title":"ALEBUND-B Advances Global Phase IIb Trial for Hyperphosphatemia Treatment with First Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1188002342","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188002342?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:03","pubTimestamp":1784635393,"startTime":"0","endTime":"0","summary":"Global Phase IIb multi-regional clinical trial for AP306, targeting hyperphosphatemia in patients on maintenance hemodialysis, has achieved a significant milestone with the first patient randomized...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","MDTX","IBBJ","159938","BK1191","BMED","09939","BK1574","09637","BK1515","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653716972","title":"Alebund Pharmaceuticals, R1 Therapeutics Partner on Global Development of AP306 Outside Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2653716972","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653716972?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:01","pubTimestamp":1784631708,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals, R1 Therapeutics partner on global development of AP306 outside Greater ChinaAlebund Pharmaceuticals granted R1 Therapeutics an exclusive license for AP306 outside mainland Chi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL6LWnHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271584","title":"Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase Iib Multi-regional Clinical Trial of AP306 for Hyperphosphatemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653271584?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:00","pubTimestamp":1784631602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA2BSV3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182922213","title":"ALEBUND-B Shares Surge Over 11% in Morning Session Following Major Institutional Buys; AP301 Nears NDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=1182922213","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182922213?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084068,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (ASX: 09637) surged more than 11% during the morning trading session. At the time of writing, the stock was up 9.62% to HK$30.54, with a turnover of HK$4.20 million. On June 29th,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","159938","BK1574","09637","BK1515","KCAI","BK4104","09939","GIC","BK1191","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172657278","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 7.56% in Regular Trading, Post-IPO Volatile Pattern Persists as Stock Retreats Over 40% From High","url":"https://stock-news.laohu8.com/highlight/detail?id=1172657278","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172657278?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:48","pubTimestamp":1783907285,"startTime":"0","endTime":"0","summary":"On July 13, Alebund Pharmaceuticals-B fell 7.56% in regular trading, trading at 27.42 HKD/share, with turnover of HKD 2.1965 million.The stock has experienced sharp volatility since listing on June...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179897569","title":"Movement Alert｜Alebund Pharmaceuticals-B Declines 5.26% in Regular Trading, Post-IPO Volatile Pattern Extends as Short-Term Profit-Taking Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1179897569","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179897569?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:41","pubTimestamp":1783669283,"startTime":"0","endTime":"0","summary":"On July 10, Alebund Pharmaceuticals-B (09637.HK) fell 5.26% in regular trading, trading at HK$28.48/share, with turnover of HK$6.41 million. The decline marks a second consecutive session of selling...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148369112","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 5.4% in Regular Trading, Short-Term Profit-Taking After Prior Session Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1148369112","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148369112?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563702,"startTime":"0","endTime":"0","summary":"On July 9, Alebund Pharmaceuticals-B declined 5.4% in regular trading, trading at approximately 31.4 HKD/share, with turnover of HKD 2.91 million. The pullback follows the previous session's sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157702683","title":"ALEBUND-B Shares Surge Over 10% Intraday Following Significant Stake Increases by GIC and LAV","url":"https://stock-news.laohu8.com/highlight/detail?id=1157702683","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157702683?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:25","pubTimestamp":1783481130,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (HKEX: 09637) surged more than 10% during intraday trading. At the time of writing, the stock is up 7.20%, trading at HK$31.28 with a turnover of HK$9.07 million. On June 29, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","GIC","BK1161","09637","BK1574","159938","BK4104","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183574653","title":"Movement Alert｜Alebund Pharmaceuticals-B Rises 5.07% in Regular Trading, Post-IPO Recovery Extends on Institutional Backing and NDA Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1183574653","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183574653?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:00","pubTimestamp":1783476037,"startTime":"0","endTime":"0","summary":"On July 8, Alebund Pharmaceuticals-B rose 5.07% in regular trading, trading at 31.3 HKD/share, with turnover of approximately 4 million HKD.The stock continues its short-term recovery trajectory...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108778007","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 8.32% in Regular Trading, Post-IPO Correction Extends After First-Day Doubling","url":"https://stock-news.laohu8.com/highlight/detail?id=1108778007","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108778007?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:38","pubTimestamp":1783301887,"startTime":"0","endTime":"0","summary":"On July 6, Alebund Pharmaceuticals-B (09637.HK) declined 8.32% in regular trading, trading at 28.22 HKD/share, with turnover of approximately 2 million HKD.The decline represents a continuation of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648693279","title":"Alebund Pharmaceuticals Jiangsu (SEHK:9637) Jumps After IPO But Is The Valuation Already Priced In","url":"https://stock-news.laohu8.com/highlight/detail?id=2648693279","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648693279?lang=en_us&edition=fundamental","pubTime":"2026-07-04 07:25","pubTimestamp":1783121101,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) (SEHK:9637) has just completed a HK$1.28b IPO in Hong Kong, an event that brings new attention to its kidney disease drug pipeline and newly listed H shares.\nSee our latest analysis for Alebund Pharmaceuticals (Jiangsu).\nThe strong first day reception for Alebund Pharmaceuticals (Jiangsu) has been followed by a 1 day share price return of 18.75% to HK$30.28, although the share price return year to date is down 34.17%. This suggests short term momentum is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9637/alebund-pharmaceuticals-jiangsu-shares/news/alebund-pharmaceuticals-jiangsu-sehk9637-jumps-after-ipo-but","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9637/alebund-pharmaceuticals-jiangsu-shares/news/alebund-pharmaceuticals-jiangsu-sehk9637-jumps-after-ipo-but","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09637","IPOS","BK4127","KCE","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125037855","title":"Major Institutional Investors Increase Holdings in ALEBUND-B, Investing Over HK$58 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1125037855","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125037855?lang=en_us&edition=fundamental","pubTime":"2026-07-03 18:12","pubTimestamp":1783073561,"startTime":"0","endTime":"0","summary":"On June 29, ALEBUND-B (HKEX: 09637) saw simultaneous share purchases from two of its significant institutional shareholders.One investor, Global Industry Company, acquired 872,000 shares at an...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIC","BK1574","BK1515","BK4104","09939","159938","BK1161","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108352969","title":"ALEBUND-B Shares Surge Over 13% in Early Trading as AP301 Nears Commercial Launch Following Recent Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1108352969","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108352969?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:38","pubTimestamp":1783046307,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (HKEX: 09637) climbed more than 13% in the morning session. At the time of writing, the stock was up 10.75% to HK$28.24, with a turnover of HK$8.44 million. According to industry...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","159938","09637","BK1515","09939","BK1574","BK1161","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110040066","title":"Movement Alert｜Alebund Pharmaceuticals-B Rises 7.92% in Regular Trading, Trading at 28.74 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1110040066","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110040066?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:50","pubTimestamp":1783043406,"startTime":"0","endTime":"0","summary":"On July 3, Alebund Pharmaceuticals-B (09637.HK) rose 7.92% in regular trading, trading at 28.74 HKD/share, with turnover of approximately 4.98 million HKD.Alebund Pharmaceuticals listed on the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189695991","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 21.6% in Regular Trading, Post-IPO Correction Approaches Offer Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1189695991","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189695991?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:48","pubTimestamp":1782956929,"startTime":"0","endTime":"0","summary":"On July 2, Alebund Pharmaceuticals-B declined 21.6% in regular trading, trading at HK$24.0/share, with turnover of HK$28.99 million.The stock listed on the Hong Kong Exchange on June 29 at an offer...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","LU1255011170.USD","02315","688180","ISBC","603259","LU0456827905.SGD","BK0028","00241","09637","AIPO","01801","BK4137","XBI","LU1303224171.USD","BK1189","LU2039709279.SGD","LU1008478684.HKD","01877","BK0239","600276","ONC","LABU","86618","IE00BPRC5H50.USD","LU1226287529.USD","BK1191","LU2328871848.SGD","BK1502","BK0216","LU1993786604.SGD","BK1571","ARTY","BK0012","LU1251922891.USD","AGIX","LU0140636845.USD","BK4585","BK1583","XLV","06618","BK0196","LU0405327494.USD","BK1161","LU0315179316.USD","01093","LU1808992512.USD","HCSG","IE00BZ08YS42.EUR","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647932823","title":"Crealights, Baige, Alebund Pharmaceuticals Jump in Hong Kong Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2647932823","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647932823?lang=en_us&edition=fundamental","pubTime":"2026-06-29 13:03","pubTimestamp":1782709403,"startTime":"0","endTime":"0","summary":"BUZZ-Crealights, Baige, Alebund Pharmaceuticals jump in Hong Kong debut** Shares of Crealights Technology1191.HKsurge 45.5% from the offer price to HK$165.9 by lunchbreak at its Hong Kong debut, outpa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL1N43103F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1537","01191","BK1147","02672","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126070700","title":"ALEBUND-B Makes Hong Kong Stock Exchange Debut: Pioneering a New Growth Model for Biotech in Vertical Chronic Disease Arena","url":"https://stock-news.laohu8.com/highlight/detail?id=1126070700","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126070700?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:19","pubTimestamp":1782703196,"startTime":"0","endTime":"0","summary":"ALEBUND-B (HKEX: 09637) commenced trading on the main board of the Hong Kong Stock Exchange today, marking its debut as the first purely nephrology-focused 18A biotech company in the Hong Kong...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","HEXmain","09939","BK4585","BK1161","BK1515","159938","09637","BK1574","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}